Bibliographic details

Mahony J B, Petrich A, Louie L, Song X Y, Chong S, Smieja M, Chernesky M, Loeb M, Richardson S.  Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus. Journal of Clinical Microbiology 2004; 42(4): 1471-1476


This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.

CRD summary

Indexing status

Subject indexing assigned by NLM

Index terms

Costs and Cost Analysis; Humans; Reagent Kits, Diagnostic /economics; Reverse Transcriptase Polymerase Chain Reaction /economics /methods; RNA, Viral /analysis; SARS Virus /genetics /isolation & purification; Sensitivity and Specificity; Severe Acute Respiratory Syndrome /virology